Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | UVV | PM |
|---|---|---|
| Price | $42.83 | $192.69 |
| Change today | ▲ 0.30% | ▲ 1.20% |
| Market cap | $1.07B | $300.33B |
| Return, 3 months | -15.4% | +6.4% |
| Return, year to date | -14.9% | +22.2% |
| Return, 1 year | -16.2% | +27.4% |
| P/E (TTM) | 56.4 | 27.7 |
| P/B | 0.8 | -35.0 |
| P/E percentile vs own 5y | 97th | 79th |
| Dividend yield | 7.66% | 3.05% |
| Revenue growth (YoY, latest qtr) | -11.8% | +10.4% |
| Net profit growth (YoY) | -158.1% | -5.2% |
| Gross margin | 16.8% | 67.5% |
| Operating margin | 6.3% | 37.7% |
| Net margin | 0.7% | 25.5% |
| Return on equity | 1.3% | – |
| Analyst target vs. price | – | +10.6% |
| Analyst buy share | – | 89% |
| RSI (14) | 40 | 56 |
| 30-day volatility | 14.4% | 19.2% |
| Max drawdown, 1 year | -26.8% | -18.5% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
